Mark E. Bunnage
EVP, Chief Scientific Officer
EVP, Chief Scientific Officer at VERTEX PHARMACEUTICALS INC / MA, filing insider transactions between 2026-02-17 and 2026-05-15.
Total Purchases
—
0 transactions
Total Sales
$2.1M
4 transactions
Companies Traded
1
4 total filings
Active Since
2026-02-17
Last: 2026-05-15
Other Reporting Insiders at Vertex Pharmaceuticals Inc / Ma
Transaction History
| Date | Ticker | Type | Shares | Price | Value | Owned After | |
|---|
| 2026-05-15 | VRTX | Sale | 33 | $453.45 | $15K | 7,284 | SEC ↗ |
| 2026-02-25 | VRTX | Sale | 620 | $486.35 | $302K | 7,284 | SEC ↗ |
| 2026-02-18 | VRTX | Sale | 1,182 | $473.68 | $560K | 8,486 |
EVP, Chief Commercial Officer
| 2026-02-17 | VRTX | Sale | 2,437 | $489.46 | $1.2M | 9,668 | SEC ↗ |
Mark E. Bunnage (Vertex Pharmaceuticals Inc / Ma) Insider Trades | Tormere